MiracleCord
- Company typePrivate
- Founded2005
- HeadquartersChicago, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What MiracleCord does
MiracleCord, Inc. is a privately held, direct-to-consumer cord blood and cord tissue banking company headquartered at 875 N Michigan Ave, Suite 3100, in Chicago, Illinois. The company collects, processes, and cryogenically stores umbilical cord blood and umbilical cord tissue stem cells for expectant parents, with marketing that targets families seeking biological insurance against over 80 treatable diseases, families with genetic disease histories (including thalassemia, sickle cell, and leukemia risk), and parents seeking sibling-protection matches. Its operations are conducted from a single, FDA-registered, CLIA-certified, and AABB-accredited laboratory with multi-system cryogenic backup, supporting annual unit processing and indefinite storage of banked specimens.
The company's core technology centers on two proprietary assets: the TimeCritical processing method, which reduces cord blood processing time to roughly half that of competitors to maximize viable stem cell recovery; and the StemCare thermal collection kit, which uses citrate phosphate dextrose (CPD) anticoagulant instead of heparin, delivering 50%+ greater stem cell yield and including an FDA-approved sterile bag for C-section deliveries. Specimens are transported from hospital to lab via a 24/7/365 next-flight-out medical courier service included in every plan. The product surface spans cord blood banking, cord tissue banking (mesenchymal stem cells for regenerative medicine), and tiered storage plans (Annual, 20-Year, and 70-Year Lifetime), all backed by a $100,000 Quality Guarantee.
MiracleCord generates revenue through subscription and multi-year prepaid storage contracts sold primarily through its own website and phone-based enrollment (888.743.2673), supported by content marketing, paid search (Google Ads, Microsoft Advertising), and native advertising (Taboola). Customers pay a $200 enrollment deposit covering the StemCare kit and shipping, with the balance due only after specimens are processed and verified, and can upgrade from Annual to 20-Year or Lifetime plans with credit applied. The firm has been operating for nearly two decades since founding in 2005, holds multiple industry awards (including four consecutive years as Best U.S. Cord Blood Bank from Global Health & Pharma), and remains an independent, founder-led entity with disclosed leadership consisting of Mark Locascio (Founder & CEO) and W. Scott Goebel (Chief Medical Director).
MiracleCord firmographics
Firmographics- Name
- MiracleCord
- Legal name
- MiracleCord, Inc.
- Website
- https://miraclecord.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
MiracleCord industry classification
Industry- Product category
- Cord Blood and Tissue Banking Services
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where MiracleCord is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MiracleCord business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D
Revenue model
- Cord Blood Banking Subscription Plans: MiracleCord offers multiple subscription tiers for cord blood and cord tissue banking: Annual storage plans (most affordable), 20-Year storage plans (most popular), and Lifetime storage plans (70-year coverage with greatest long-term savings). Customers pay a $200 deposit at enrollment and the balance after stem cells are received and processed. Plans can be changed to longer-term options with credit applied.
- Cord Tissue Banking: Optional add-on service for banking umbilical cord tissue in addition to cord blood, providing additional stem cell types (mesenchymal stem cells) for future regenerative medicine applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Annual Storage Plan - Most affordable option |
| Subscription | Multi-year contract | 20-Year Storage Plan - Most popular option |
| Subscription | Multi-year contract | Lifetime Storage Plan - Greatest long-term savings |
| One time/ perpetual license | Pay-as-you-go | Enrollment Deposit |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
MiracleCord product offering
Product offeringCore offering
MiracleCord provides private cord blood and cord tissue banking services for expectant parents. The company ships a proprietary StemCare collection kit to enrollees, processes specimens at its Chicago lab using an exclusive TimeCritical method to maximize stem cell recovery, and cryogenically stores the units under Annual, 20-Year, or Lifetime (70-year) subscription plans. The service is bundled with a $100,000 Quality Guarantee and a 24/7 medical courier logistics operation.
Product overview
MiracleCord offers a unified private cord blood and cord tissue banking service as a single integrated offering. The core service includes collecting cord blood and cord tissue via their proprietary StemCare Collection Kit, processing specimens using their exclusive TimeCritical Processing method, and providing long-term cryogenic storage through flexible plans (Annual, 20-Year, and Lifetime). The company emphasizes advanced technology, fast processing times, and high stem cell recovery rates as key differentiators, supported by a $100,000 Quality Guarantee and AABB accreditation.
Differentiator
Problem solved
Functional benefit
Brands
- TimeCritical Processing: MiracleCord's exclusive cord blood processing method that processes specimens in significantly less time than most other cord blood banks, yielding considerably more viable stem cells.
- StemCare Collection Kit
Products and services
- Cord Blood Banking Private cord blood banking service that collects, processes using TimeCritical methodology, and cryogenically stores umbilical cord blood stem cells for potential future medical treatments for the donor child, siblings, and family members. Delivered to U.S. expectant parents through website or phone enrollment with bundled 24/7 medical courier service.
- Cord Tissue Banking Service that collects, processes, and cryogenically stores umbilical cord tissue stem cells containing mesenchymal stem cells (MSCs) used in regenerative medicine applications. Available to expectant parents as an optional add-on to cord blood banking plans.
Quantifiable outcome
- 75% probability of suitable HLA match for full siblings
- +3 more outcomes
Companies that use MiracleCord
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
MiracleCord technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
MiracleCord partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
MiracleCord competitors and assessment
Company assessmentDirect peers
- ViaCord: ViaCord is a private (family) cord blood and cord tissue bank offering collection, processing, and cryogenic storage directly to expectant parents. It is a direct competitor to MiracleCord with overlapping products, customer base, and subscription pricing model.
- Cryo-Cell International: Cryo-Cell is a publicly traded cord blood banking services company offering private and public cord blood banking plus related cellular services. It is a direct peer to MiracleCord in private family banking with similar product offerings.
- StemCyte: StemCyte operates both public and private cord blood banking with FDA and AABB-relevant infrastructure, providing direct competition to MiracleCord for expectant parents seeking private family banking services.
- FamilyCord: FamilyCord is a private cord blood and cord tissue bank serving U.S. families with collection kits, processing, and long-term storage plans — directly comparable to MiracleCord's product set and target customer.
- AlphaCord: AlphaCord is a U.S. private cord blood bank offering collection, processing, and storage to expectant parents, competing with MiracleCord on price, accreditation, and service quality.
- New England Cord Blood Bank: New England Cord Blood Bank is a private (and hybrid public/private) cord blood bank operating in the U.S., directly comparable to MiracleCord in products, customers, and AABB-style accreditation positioning.
- Maze Cord Blood: Maze Cord Blood is a U.S. private cord blood and tissue banking service targeting expectant parents, directly competing with MiracleCord on collection kit design, processing, and storage subscription plans.
- CariCord: CariCord operates a U.S. family cord blood banking service affiliated with the University of Colorado Cord Blood Bank, offering comparable private storage products and competing for the same expectant-parent customer.
- Americord Registry: Americord is a private cord blood and cord tissue bank with a focus on processing speed and stem cell yield — directly comparable to MiracleCord's TimeCritical positioning and overall subscription-based service model.
Broad incumbents
- Cord Blood Registry (CBR): CBR is one of the largest U.S. private cord blood banks, historically affiliated with AMAG Pharmaceuticals. It directly competes with MiracleCord on cord blood and cord tissue storage and is the category leader MiracleCord benchmarks itself against.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
MiracleCord social profiles
Digital presenceMiracleCord compliance and trust
Trust signalCompliance5 records
MiracleCord financial estimates
Financial estimateRevenue estimate
Valuation estimate
MiracleCord leadership team
Management profileNumber of profiles
Profiles2 records
MiracleCord funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MiracleCord M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MiracleCord
What does MiracleCord do?
MiracleCord provides private cord blood and cord tissue banking services for expectant parents. The company ships a proprietary StemCare collection kit to enrollees, processes specimens at its Chicago lab using an exclusive TimeCritical method to maximize stem cell recovery, and cryogenically stores the units under Annual, 20-Year, or Lifetime (70-year) subscription plans. The service is bundled with a $100,000 Quality Guarantee and a 24/7 medical courier logistics operation.
Is MiracleCord a public or private company?
MiracleCord is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MiracleCord founded?
MiracleCord was founded in 2005. It employs 1 to 10 people.
Where is MiracleCord based?
MiracleCord is headquartered in Chicago, United States, in the North America region.
How does MiracleCord make money?
Two revenue lines are on record. Cord Blood Banking Subscription Plans are the primary driver. The others are cord Tissue Banking.
Who are MiracleCord's main competitors?
Direct peers on record are ViaCord, Cryo-Cell International, StemCyte, FamilyCord, AlphaCord, New England Cord Blood Bank, Maze Cord Blood, CariCord and Americord Registry. Cord Blood Registry (CBR) is listed as a broad incumbent.
Does MiracleCord have an API?
No public API is recorded for MiracleCord.
What industry is MiracleCord in?
MiracleCord's product category is Cord Blood and Tissue Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991.